Intelligence · Patents
Patents expiring in 2027
Annual patent cliff calendar for 2027 — US pharmaceutical patents by expiration date.
- Patents
- 578
Quick answer
578 indexed pharmaceutical patents have expiration dates in 2027. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7172876
Method of screening therapeutic agents for nerve degeneration associated diseases
granted -
US 7172869
Methods for transfecting T cells
granted -
US 7173112
Antibody to GALP and uses thereof
granted -
US 7172768
Storage stable powder compositions of interleukin-4 receptor
granted -
US 7176302
Liposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotides
granted -
US 7176233
Salinosporamides and methods for use thereof
granted -
US 7176201
Modulation of anxiety through blockade of anandamide hydrolysis
granted -
US 7176232
Salinosporamides and methods for use thereof
granted -
US 7176244
Use of 2-nitropropanol, 2-nitroethane, and 2-nitroethanol for control of microbial pathogens
granted -
US 7176211
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
granted -
US 7176019
RICK3 nucleic acids and proteins
granted -
US 7176010
Isolated human protein having esterase activity and DNA encoding the same
granted -
US 7176208
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
granted -
US 7176280
Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use
granted -
US 7175990
Method of determining endometrial receptivity
granted -
US 7175981
Method of diagnosing stage or aggressiveness of breast and prostate cancer based on levels of fatty acid binding proteins
granted -
US 7175848
Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolized ricin
granted -
US 7175845
Monoclonal antibodies against ricin toxin and methods of making and using thereof
granted -
US 7175843
Methods for selectively stimulating proliferation of T cells
granted -
US 7175838
Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state
granted -
US 7176179
Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
granted -
US 7176283
Protease-activated receptor 3 and uses thereof
granted -
US 7175830
Imaging of drug accumulation as a guide to antitumor therapy
granted -
US 7179462
α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof
granted -
US 7179823
5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
granted -
US 7179217
Apparatus for enhancing tissue repair in mammals
granted -
US 7179888
Antigenic, non-toxic mutants of Clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith
granted -
US 7179621
Pigment epithelium-derived factor: sequence of the PEDF gene
granted -
US 7179588
Assay for the detection of paclitaxel resistant cells in human tumors
granted -
US 7179826
Compositions useful as inhibitors of protein kinases
granted -
US 7179834
Salinosporamides and methods for use thereof
granted -
US 7179827
Thiazoles and methods of their use
granted -
US 7179815
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
granted -
US 7179894
Combinatorial selection of oligonucleotide aptamers
granted -
US 7179445
Cobalamin conjugates useful as imaging and therapeutic agents
granted -
US 7179794
Multivalent macrolide antibiotics
granted -
US 7179899
Composite antibodies of humanized human subgroup IV light chain capable of binding to TAG-72
granted -
US 7183389
Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
granted -
US 7182944
Methods of increasing distribution of nucleic acids
granted -
US 7183415
Quinoline compound
granted -
US 7183323
Sodium channel modulators
granted -
US 7183401
NOEY2 gene compositions and methods of use
granted -
US 7183276
Azole compounds
granted -
US 7183334
Low temperature molding compositions with solid thermoplastic elastomer thickeners and fiber reinforcement
granted -
US 7183313
Keto cannabinoids with therapeutic indications
granted -
US 7183292
Substituted pyrrolidine and related compounds
granted -
US 7183272
Crystal forms of oxcarbazepine and processes for their preparation
granted -
US 7183268
2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents
granted
Frequently asked questions
How many pharma patents expire in 2027?
578 published patents in our USPTO index have expiration dates falling in calendar year 2027.